Mark Moffat

484 total citations
14 papers, 402 citations indexed

About

Mark Moffat is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark Moffat has authored 14 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark Moffat's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), Virus-based gene therapy research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Mark Moffat is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), Virus-based gene therapy research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Mark Moffat collaborates with scholars based in United States, Singapore and United Kingdom. Mark Moffat's co-authors include Karen L. O’Malley, Shou C. Wong, Steve Harmon, Young J. Oh, George T. Coker, Ann Uhland‐Smith, Robert J. Young, Mara C. Inniss, Lin Zhang and Wendy L. Cox and has published in prestigious journals such as Journal of Neurochemistry, Experimental Neurology and Biotechnology and Bioengineering.

In The Last Decade

Mark Moffat

14 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Moffat United States	11	259	112	109	61	43	14	402
Maria M Campos United States	15	409 1.6×	75 0.7×	67 0.6×	25 0.4×	107 2.5×	33	639
Lingxin Kong China	12	160 0.6×	48 0.4×	119 1.1×	63 1.0×	23 0.5×	21	375
Caroline Houde Canada	8	328 1.3×	61 0.5×	84 0.8×	45 0.7×	148 3.4×	8	567
Géraldine Ferjoux France	8	175 0.7×	65 0.6×	31 0.3×	191 3.1×	21 0.5×	9	430
Bartholomew J. Naughton United States	8	269 1.0×	36 0.3×	81 0.7×	51 0.8×	13 0.3×	11	464
Qing Ruan United States	13	487 1.9×	103 0.9×	162 1.5×	47 0.8×	72 1.7×	15	661
Meri Mazzoni Italy	10	307 1.2×	43 0.4×	21 0.2×	39 0.6×	18 0.4×	13	503
Rama Thimmapaya United States	9	344 1.3×	64 0.6×	48 0.4×	15 0.2×	19 0.4×	12	432
Rameeza Allie United States	9	414 1.6×	94 0.8×	60 0.6×	11 0.2×	29 0.7×	11	725
Naseebullah Kakar Pakistan	13	184 0.7×	15 0.1×	148 1.4×	52 0.9×	6 0.1×	27	377

Countries citing papers authored by Mark Moffat

Since Specialization

Citations

This map shows the geographic impact of Mark Moffat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Moffat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Moffat more than expected).

Fields of papers citing papers by Mark Moffat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Moffat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Moffat. The network helps show where Mark Moffat may publish in the future.

Co-authorship network of co-authors of Mark Moffat

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Moffat. A scholar is included among the top collaborators of Mark Moffat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Moffat. Mark Moffat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Clarke, Howard R. G., Anke Mayer‐Bartschmid, Mark Moffat, et al.. (2024). When will we have a clone? An industry perspective on the typical CLD timeline. Biotechnology Progress. 40(4). e3449–e3449. 3 indexed citations

Zhang, Ying, et al.. (2022). A genetic off‐target event in a site‐specific integration cell line expressing monoclonal antibody has no impact on commercial suitability. Biotechnology Progress. 39(2). e3320–e3320. 1 indexed citations

Moffat, Mark, et al.. (2021). CHOK1SV GS‐KO SSI expression system: A combination of the Fer1L4 locus and glutamine synthetase selection. Biotechnology Progress. 37(4). e3137–e3137. 14 indexed citations

Zhang, Lin, Mara C. Inniss, Shu Han, et al.. (2015). Recombinase‐mediated cassette exchange ( RMCE ) for monoclonal antibody expression in the commercially relevant CHOK1SV cell line. Biotechnology Progress. 31(6). 1645–1656. 75 indexed citations

Ogawa, Shinji, Takashi Ochi, Hideaki Shimada, et al.. (2010). Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development. Hepatology Research. 40(11). 1128–1141. 54 indexed citations

Runnels, Herbert A., Debra M. Meyer, Michelle Evans, et al.. (2010). Human monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studies. Advances in Therapy. 27(7). 458–475. 5 indexed citations

Kennard, Malcolm L., Danika L. Goosney, Lin Zhang, et al.. (2009). The generation of stable, high MAb expressing CHO cell lines based on the artificial chromosome expression (ACE) technology. Biotechnology and Bioengineering. 104(3). 540–553. 37 indexed citations

Moffat, Mark, Steve Harmon, John W. Haycock, & Karen L. O’Malley. (1997). l-Dopa and Dopamine-Producing Gene Cassettes for Gene Therapy Approaches to Parkinson's Disease. Experimental Neurology. 144(1). 69–73. 20 indexed citations

Oh, Young J., Mark Moffat, Shou C. Wong, et al.. (1996). A herpes simplex virus-1 vector containing the rat tyrosine hydroxylase promoter directs cell type-specific expression of beta-galactosidase in cultured rat peripheral neurons. Molecular Brain Research. 35(1-2). 227–236. 10 indexed citations

10.

O’Malley, Karen L., Steve Harmon, Mark Moffat, Ann Uhland‐Smith, & Shou C. Wong. (1995). The Human Aromatic l‐Amino Acid Decarboxylase Gene Can Be Alternatively Spliced To Generate Unique Protein Isoforms. Journal of Neurochemistry. 65(6). 2409–2416. 59 indexed citations

11.

Oh, Young J., Shou C. Wong, Mark Moffat, & Karen L. O’Malley. (1995). Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line. Neurobiology of Disease. 2(3). 157–167. 49 indexed citations

12.

Wong, Shou C., Mark Moffat, George T. Coker, John P. Merlie, & Karen L. O’Malley. (1995). The 3′ Flanking Region of the Human Tyrosine Hydroxylase Gene Directs Reporter Gene Expression in Peripheral Neuroendocrine Tissues. Journal of Neurochemistry. 65(1). 23–31. 18 indexed citations

13.

Wong, Shou C., Mark Moffat, & Karen L. O’Malley. (1994). Sequences Distal to the AP1/E Box Motif Are Involved in the Cell Type‐Specific Expression of the Rat Tyrosine Hydroxylase Gene. Journal of Neurochemistry. 62(5). 1691–1697. 19 indexed citations

14.

Coker, George T., et al.. (1990). Species and Regional Differences in the Expression of Cell‐Type Specific Elements at the Human and Rat Tyrosine Hydroxylase Gene Loci. Journal of Neurochemistry. 55(6). 2149–2152. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact